Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease (IMPACT-ALD): Aim 1

NCT06305624 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT06305624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06305624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease (IMPACT-ALD): Aim 1
Lead sponsor
University of Wisconsin, Madison
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2024
Completion date
October 31, 2027
Enrollment
298 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, alcohol-related liver disease